Micheli; Fabrizio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Micheli; Fabrizio.The latest application filed is for "small-molecule pi5p4k alpha/beta inhibitors and methods of treatment using same".

Company Profile

7.32.44

Micheli; Fabrizio - Verona IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Small-Molecule PI5P4K alpha/beta Inhibitors and Methods of Treatment Using Same App 20210292326 - Ha; Ya ; et al.	2021-09-23
Dopamine D.sub.3 receptor antagonist compounds Grant 10,654,842 - Cremonesi , et al.	2020-05-19
Substituted 3,6-diazabicyclo[3.2.0]heptanes Grant 10,584,135 - Cremonesi , et al.	2020-03-10
Dopamine D3 receptor antagonists having a morpholine moiety Grant 10,577,361 - Cremonesi , et al.	2020-03-03
Dopamine D3 Receptor Antagonist Compounds App 20190300514 - Cremonesi; Susanna ; et al.	2019-10-03
Dopamine D3 Receptor Antagonists Having A Bicyclo Moiety App 20190194225 - Cremonesi; Susanna ; et al.	2019-06-27
Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulators Grant 10,273,244 - Micheli , et al.	2019-04-30
Dopamine D3 receptor antagonists Grant 10,239,870 - Cremonesi , et al.	2019-03-26
Dopamine D3 Receptor Antagonists Having A Morpholine Moiety App 20180297990 - Cremonesi; Susana ; et al.	2018-10-18
Dopamine D3 Receptor Antagonists App 20180282318 - Cremonesi; Susanna ; et al.	2018-10-04
Dopamine D3 Receptor Antagonists Having A Bicyclo Moiety App 20180222918 - Cremonesi; Susanna ; et al.	2018-08-09
Dopamine D3 receptor antagonist compounds Grant 10,000,477 - Cremonesi , et al. June 19, 2	2018-06-19
N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system Grant 9,920,053 - Cremonesi , et al. March 20, 2	2018-03-20
Spirocyclic derivatives Grant 9,908,897 - Cremonesi , et al. March 6, 2	2018-03-06
Dopamine D3 Receptor Antagonist Compounds App 20170334895 - Cremonesi; Susanna ; et al.	2017-11-23
2-[bis(4-fluorophenyl)methyl]-2,7-diazaspiro[4.5]decan-10-one Derivatives And Related Compounds As Inhibitors Of The Human Dopamine-active-transporter (dat) Protein For The Treatment Of E.g. Attention Deficit Disorder (add) App 20170260185 - SEMERARO; Teresa ; et al.	2017-09-14
Spirocyclic derivatives App 20170253615 - CREMONESI; Susanna ; et al.	2017-09-07
N-(hetero)aryl-substituted Heteroyclic Derivatives Useful For The Treatment Of Diseases Or Conditions Related To The Central Nervous System App 20170253592 - CREMONESI; Susanna ; et al.	2017-09-07
Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D.sub.3 receptors Grant 8,263,782 - Arista , et al. September 11, 2	2012-09-11
Use Of Azabicyclo Hexane Derivatives App 20120196910 - HAMPRECHT; Dieter ; et al.	2012-08-02
Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine D.sub.3 receptors Grant 8,222,266 - Bertani , et al. July 17, 2	2012-07-17
Azabicyclo [3. 1. O] hexyl derivatives as modulators of dopamine D3 receptors Grant 8,178,549 - Bertani , et al. May 15, 2	2012-05-15
Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors Grant 8,163,927 - Bertani , et al. April 24, 2	2012-04-24
Spirocompounds useful as modulators for dopamine D3 receptors Grant 8,030,322 - Bertani , et al. October 4, 2	2011-10-04
7-pyrazolylbenzazepines having affinity for D3 receptor Grant 8,003,638 - Hamprecht , et al. August 23, 2	2011-08-23
Compounds having affinity for dopamine D3 receptor and uses thereof Grant 7,989,444 - Bonanomi , et al. August 2, 2	2011-08-02
3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors Grant 7,947,683 - Bonanomi , et al. May 24, 2	2011-05-24
Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors Grant 7,875,643 - Hamprecht , et al. January 25, 2	2011-01-25
Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine D3 receptor modulators Grant 7,863,299 - Capelli , et al. January 4, 2	2011-01-04
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D.sub.3 receptors Grant 7,855,298 - Arista , et al. December 21, 2	2010-12-21
Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptor Grant 7,807,698 - Arista , et al. October 5, 2	2010-10-05
3-triazolylthiaalkyl-3-azabicyclo (3-1-O) hexanes and their use as dopamine D3 receptor ligands Grant 7,803,820 - Andreotti , et al. September 28, 2	2010-09-28
Triazole derivatives as modulators of dopamine D3 receptors Grant 7,799,815 - Bonanomi , et al. September 21, 2	2010-09-21
Azabicyclo [3. 1. O] Hexyl Derivatives As Modulators Of Dopamine D3 Receptors App 20100210672 - Bertani; Barbara ; et al.	2010-08-19
Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine D3 receptors Grant 7,776,904 - Gentile , et al. August 17, 2	2010-08-17
Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine D3 receptors Grant 7,745,458 - Arista , et al. June 29, 2	2010-06-29
Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors App 20100160336 - Arista; Luca ; et al.	2010-06-24
Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors App 20100152195 - Arista; Luca ; et al.	2010-06-17
Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione Grant 7,727,988 - Bertani , et al. June 1, 2	2010-06-01
Spirocompounds Useful As Modulators For Dopamine D3 Receptors App 20100063078 - Bertani; Barbara ; et al.	2010-03-11
Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors App 20100063097 - Bertani; Barbara ; et al.	2010-03-11
Azabicyclic Compounds As Inhibitors Of Monoamines Reuptake App 20100035914 - Bertani; Barbara ; et al.	2010-02-11
Azabicyclic Compounds As Serotonin, Dopamine And Norepinephrine Re-uptake Inhibitors App 20100029740 - Bonanomi; Giorgio ; et al.	2010-02-04
Compounds Having Affinity For Dopamine D3 Receptor And Uses Thereof" App 20100016287 - Bonanomi; Giorgio ; et al.	2010-01-21
Azab I Cyclo [3 . 1 . 0] Hexane Derivatives As Dopamin D3 Receptor Modulators App 20090326011 - Arista; Luca ; et al.	2009-12-31
3-azabicyclo [4. 1. 0] Heptane Derivatives For The Treatment Of Depression App 20090281135 - Di Fabio; Romano ; et al.	2009-11-12
Azabicyclo (3, 1, 0) Hexan Derivatives Useful As Modulators Of Dopamine D3 Receptors App 20090221618 - Arista; Luca ; et al.	2009-09-03
Triazole Derivatives As Modulators Of Dopamine D3 Receptors App 20090221593 - Bonanomi; Giorgio ; et al.	2009-09-03
Use of Azabicyclo Hexane Derivatives App 20090036461 - Hamprecht; Dieter ; et al.	2009-02-05
Azabicyclo [3.1.0] Hexylphenyl Derivatives As Modulators Of Dopamine D3 Receptors App 20090030062 - Gentile; Gabriella ; et al.	2009-01-29
7-Pyrazolylbenzazepines Having Affinity For D3 Receptor App 20080312213 - Hamprecht; Dieter ; et al.	2008-12-18
Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists Grant 7,462,622 - Di Fabio , et al. December 9, 2	2008-12-09
Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine App 20080269195 - Bonanomi; Giorgio ; et al.	2008-10-30
Triazolyl Derivatives of Azabicyclo [3.1.0] Hexane as Dopamine D3 Receptor Modulators App 20080242715 - Capelli; Anna Marie ; et al.	2008-10-02
3-Triazolylthiaalkyl-3-Azabicyclo (3-1-O) Hexanes and Their Use as Dopamine D3 Receptor Ligands App 20080176917 - Andreotti; Daniele ; et al.	2008-07-24
Azabicyclo (3.1.0) Hexane Derivatives Useful as Modulators of Dopamine D3 Receptors App 20080167357 - Hamprecht; Dieter ; et al.	2008-07-10
Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents) App 20080139532 - Arista; Luca ; et al.	2008-06-12
CRF receptor antagonists Grant 7,329,667 - Di Fabio , et al. February 12, 2	2008-02-12
Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione App 20070249642 - Bertani; Barbara ; et al.	2007-10-25
Substituted pyrrolo[2,3-d]pyrimidines as antagonists of the corticotropin releasing factor (CRF) Grant 7,279,474 - Capelli , et al. October 9, 2	2007-10-09
Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists Grant 7,273,871 - Di Fabio , et al. September 25, 2	2007-09-25
Chemical Compounds App 20070219232 - Di Fabio; Romano ; et al.	2007-09-20
Compounds having activity at 5ht2c receptor and uses thereof App 20070191457 - Bonanomi; Giorgio ; et al.	2007-08-16
Chemical compounds Grant 7,253,284 - Di Fabio , et al. August 7, 2	2007-08-07
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine d3 receptors App 20070142438 - Arista; Luca ; et al.	2007-06-21
Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists App 20070066640 - Castiglioni; Emiliano ; et al.	2007-03-22
Compounds having activity at 5ht2c receptor and uses thereof App 20060281786 - Hamprecht; Dieter ; et al.	2006-12-14
Compounds having activity at 5ht2c receptor and uses thereof App 20060205788 - Damiani; Federica ; et al.	2006-09-14
Compounds having affinity at 5ht2C receptor and use thereof in therapy App 20050203079 - Damiani, Federica ; et al.	2005-09-15
Corticotropin releasing factor antagonists App 20050054661 - Di Fabio, Romano ; et al.	2005-03-10
Chemical compounds App 20040242623 - Difabio, Romano ; et al.	2004-12-02
Crf receptor antagonists App 20040235871 - Di Fabio, Romano ; et al.	2004-11-25
Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) App 20040176400 - Capelli, Anna Maria ; et al.	2004-09-09
Chemical compounds App 20040171607 - Di Fabio, Romano ; et al.	2004-09-02
Tetrahydroquinolines as NMDA antagonists Grant 5,977,136 - Di Fabio , et al. November 2, 1	1999-11-02
Indole derivatives Grant 5,686,461 - Cugola , et al. November 11, 1	1997-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.